Package inserts for antituberculosis drugs and tuberculins.
D000995:Antitubercular Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003276:Contraceptives, Oral; D004347:Drug Interactions; D004348:Drug Labeling / Q000592:standards*; D004357:Drug Synergism; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects; D009164:Mycobacterium Infections / Q000188:drug therapy; D010045:Outpatients; D011718:Pyrazinamide / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D014373:Tuberculin / Q000008:administration & dosage / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D000995:Antitubercular Agents; D003276:Contraceptives, Oral; D014373:Tuberculin; D011718:Pyrazinamide; D007538:Isoniazid; D012293:Rifampin